http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59116250-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_729e9867bcb2243a88536642d25910ec
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-00
filingDate 1982-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ded5e896589ba9d5d20ce713cee2043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a30f6a8f998991473378149d5e751c2a
publicationDate 1984-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S59116250-A
titleOfInvention Optical resolution of alpha-p-tolylethylamine
abstract PURPOSE: To obtain an optically active substance of the titled compound useful as an optically resolving agent in high purity in high yield easily, by crystallizing preferentially an optically active p-hydroxybenzoate from a solution of a p-hydroxybenzoate of α-p-tolylethylamine. n CONSTITUTION: A salt of (±)-α-p-tolylethylamine of α-p-tolylethylamine containing an excess of one of the optically active forms of it and p-hydroxybenzoic acid is dissolved in a liquid diluent under heating to give a supersaturated solution. A small amount of optical active salt of α-p-tolylethylamine and p- hydroxybenzoate is seeded to the supersaturated solution, and the same optically active salt as the seeded optically active salt is crystallized and separated to give the desired compound. Methanol or ethanol may be cited as the liquid duluent. This process shows buffer actuon on crystallization pressure of antipode, and always keeps a crystallization solution and a crystal phase in a stabilized phase equilibrium relationship. n COPYRIGHT: (C)1984,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0416762-Y2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108658784-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108658784-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6278554-U
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007057468-A1
priorityDate 1982-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25201405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226598148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414847683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422708311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID577386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 37.